Corbus Pharmaceuticals Holdings (CRBP) EBT Margin Growth (3y) (2018 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) EBT Margin Growth (3y) (2018 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 49,756.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 441.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -1.29 Mn |
| Jun 30, 2021 | -1.08 Mn |
| Mar 31, 2021 | -115,242.00 |
| Sep 30, 2020 | -189,254.00 |
| Jun 30, 2020 | -1.12 Mn |
| Mar 31, 2020 | -111,430.00 |
| Sep 30, 2019 | -23,969.00 |
| Jun 30, 2019 | 106,328.00 |
| Mar 31, 2019 | -65,782.00 |
| Dec 31, 2018 | -794,394.00 |
| Sep 30, 2018 | -1,881.00 |
| Jun 30, 2018 | 83,472.00 |